Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-01-18-Speech-3-359-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| lpv:document identification number |
"en.20120118.26.3-359-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:translated text |
"Madam President, I would firstly like to thank Parliament, in particular the rapporteur, Christa Klaß, and also the shadows for their constructive engagement with the Council and the Commission.
Thank you for your attention.
This has resulted in a compromise text that provides an excellent basis for strengthening the internal market for biocidal products while at the same time ensuring a high level of protection for humans and the environment.
The Commission is also very happy with the pragmatic solutions that have been found for difficult issues, such as the scope of EU centralised procedure for products, the transitional arrangements for moving from existing directives to the new regulation and the rules for dealing with treated articles.
Throughout the negotiating process the Commission has insisted on the need to ensure that the European Chemicals Agency in Helsinki would have the necessary resources to carry out all the tasks it has been given under the regulation. These have been expanded considerably during the course of the negotiations. To this end, the Commission has produced a revised financial statement, and I would like to take this opportunity to remind Parliament of the need for the appropriate amounts to be included in the future budget allocations for the agency. I would also like to thank you in advance.
While the Commission is supportive of the compromise text and does not wish to stand in the way of its adoption, there are two important issues which it would like to draw to the attention of Parliament. Firstly, the Commission considers that, to be consistent with the Treaty, the regulation setting the fees to be paid to the chemical agency should be in the form of a delegated act rather than an implementing measure. The Commission therefore informs Parliament that it reserves its right to pursue the legal remedies provided by the Treaty in order to seek clarification by the Court of Justice.
Secondly, in relation to the definition of nanomaterials, the Commission believes that it would have been better to include a simple cross-reference to the recent Commission recommendation on nanomaterials rather than to embed the definition in the text of the regulation itself. Therefore the Commission would like to emphasise that the approach taken in relation to the biocides regulation should not be understood as constituting a precedent for future cases.
The Commission will make declarations on these two issues, and it will also make a declaration on setting the level of the fee for applications for mutual recognition payable to the European Chemicals Agency.
Having said this, I would like to make it clear that we regard the compromise text to be voted on during this plenary as an excellent basis, both for strengthening the internal market for biocidal products and for ensuring a high level of protection for humans and the environment. This is the most important thing, is it not?
This regulation strikes the right balance. It will ensure that we can develop safer products and use biocides efficiently to control the spread of harmful pests and germs, but it will also keep the most dangerous substances off the market, particularly those that cause cancer or fertility problems, and will also keep them out of the environment."@en1
|
| lpv:unclassifiedMetadata | |
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples